From the Philadelphia Inquirer. July 7th 2014
Drug companies have been hotly pursuing a fix for female sexual dysfunction ever since Viagra was approved 16 years ago.
They keep falling short.
The letdowns have been seen as evidence that the fairer sex's sexual problems are tougher to define, diagnose, and safely treat than men's.
But now there's a new theory about why women and drug developers can't get any satisfaction:
The U.S. Food and Drug Administration is sexist.
"There are 26 drugs for [sexually dysfunctional] men, zero for women," said Irwin Goldstein, president of the Institute for Sexual Medicine in San Diego. "The FDA has gender issues."
"Women's sexual health is held to a different standard of risk-benefit by the FDA than male sexual health," said Sheryl A. Kingsberg, a clinical psychologist at University Hospitals Case Medical Center in Cleveland.
That contention has been made for years by experts who are also paid pharmaceutical consultants. But over the last six months, the complaint has grown into a testy advocacy crusade. Even the Score: A Campaign for Women's Sexual Health Equity was launched last month by women's groups, complete with a website (eventhescore.org), petition, and congressional supporters.
Read the rest of the article here